Cover Image

Smell disturbance among Saudi COVID-19 Patients

Objectives: Recently, COVID-19 was declared a pandemic, and since then, many studies have examined its symptomatology. In this study, we aimed to focus on Saudi patients with COVID-19 who also experienced smell dysfunction. We hypothesized that there would be a high percentage of COVID-19 patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmad S Alroqi (Author), Leen Othaim Alothaim (Author), Shoag Jaza Albugami (Author), Noura Othaim Alothaim (Author), Almaha A Alqabbani (Author), Saud R Alromaih (Author), Sama Obaid Alharbi (Author), Fatima Saad Alangari (Author), Danyah Khalid Saja (Author), Sarah Saeed AlMutawa (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: Recently, COVID-19 was declared a pandemic, and since then, many studies have examined its symptomatology. In this study, we aimed to focus on Saudi patients with COVID-19 who also experienced smell dysfunction. We hypothesized that there would be a high percentage of COVID-19 patients with smell dysfunction in the Saudi population. Methodology: A quantitative, observational, cross-sectional study was carried out in Riyadh, Saudi Arabia in August 2020 and was designed to assess anosmia and hyposmia in Saudi patients with a positive COVID-19 test. Only Saudi adults with confirmed COVID-19 were enrolled in the study. We distributed an electronic, self-administered questionnaire through social media platforms, and personal contact to query the patients who had a positive COVID-19 test. Results: The study included 1005 patients, of whom 63.5% were female. More than three quarters (76.7%) were between the ages of 18 and 38 years. Most of them (74.1%) were healthy, while some of them (25%) reported associated comorbidities. Overall, approximately three-quarters (72%) of the participants developed smell dysfunction during the infection period, with (17.3%) experiencing a partial loss of smell (hyposmia), and (54%) experiencing a complete loss of smell (anosmia). Conclusions: Our study revealed that approximately three-quarters (72%) of the participants with COVID-19 developed smell dysfunction during the infection period, which supports our hypothesis.
Item Description:2589-627X
2589-6288
10.4103/jnsm.jnsm_148_20

Similar Items